Table of Content

1 INTRODUCTION 30
1.1 OBJECTIVES OF THE STUDY 30
1.2 MARKET DEFINITION 30
1.3 STUDY SCOPE 31
FIGURE 1 ENTERIC DISEASE TESTING MARKET SEGMENTATION 31
1.3.1 REGIONAL SEGMENTATION 31
1.4 INCLUSIONS & EXCLUSIONS 32
1.4.1 PERIODIZATION CONSIDERED 33
1.5 CURRENCY CONSIDERED 33
TABLE 1 USD EXCHANGE RATES, 2015–2019 34
1.6 STAKEHOLDERS 34
2 RESEARCH METHODOLOGY 35
2.1 RESEARCH DATA 35
FIGURE 2 ENTERIC DISEASE TESTING MARKET: RESEARCH DESIGN 35
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 36
2.1.2 PRIMARY DATA 37
2.1.2.1 Key industry insights 37
2.1.2.2 Breakdown of primary interviews 38
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 38
2.2 MARKET SIZE ESTIMATION 39
2.2.1 BOTTOM-UP APPROACH 39
2.2.2 TOP-DOWN APPROACH 39
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY APPROACH 40
2.3 DATA TRIANGULATION 41
FIGURE 5 DATA TRIANGULATION METHODOLOGY 41
2.3.1 ENTERIC DISEASE TESTING MARKET SIZE ESTIMATION: SUPPLY SIDE 42
FIGURE 6 MARKET SIZE ESTIMATION OF ENTERIC DISEASE TESTING MARKET, 2020 42
2.3.2 ENTERIC DISEASE TESTING MARKET SIZE ESTIMATION: DEMAND SIDE 42
2.4 RESEARCH ASSUMPTIONS 43
2.5 RESEARCH LIMITATIONS 44
2.6 MARKET SCENARIOS CONSIDERED FOR THE IMPACT OF COVID-19 44
2.7 SCENARIO-BASED MODELLING 45
2.8 COVID-19 HEALTH ASSESSMENT 45
FIGURE 7 COVID-19: GLOBAL PROPAGATION 45
FIGURE 8 COVID-19 PROPAGATION: SELECT COUNTRIES 46
2.9 COVID-19 ECONOMIC ASSESSMENT 47
FIGURE 9 REVISED GROSS DOMESTIC PRODUCT FORECASTS FOR SELECT G20 COUNTRIES IN 2020 47
2.9.1 COVID-19 ECONOMIC IMPACT?SCENARIO ASSESSMENT 48
FIGURE 10 CRITERIA IMPACTING GLOBAL ECONOMY 48
FIGURE 11 SCENARIOS IN TERMS OF RECOVERY OF GLOBAL ECONOMY 49
3 EXECUTIVE SUMMARY 51
4 PREMIUM INSIGHTS 54
4.1 OPPORTUNITIES IN THE ENTERIC DISEASE TESTING MARKET 54
4.2 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET, BY END USE & COUNTRY 55
4.3 ENTERIC DISEASE TESTING MARKET, BY PATHOGEN 55
FIGURE 18 SALMONELLA TO ACCOUNT FOR THE LARGEST SHARE FOR ENTERIC DISEASE TESTING IN 2020 55
4.4 ENTERIC DISEASE TESTING MARKET, BY TECHNOLOGY 56
4.5 ENTERIC DISEASE TESTING MARKET IN FOOD, BY REGION & SUBSEGMENT 56
4.6 ENTERIC DISEASE TESTING MARKET: MAJOR REGIONAL SUBMARKETS 57
5 MARKET OVERVIEW 58
5.1 INTRODUCTION 58
5.2 MACROECONOMIC INDICATORS 58
5.2.1 INCREASE IN FOODBORNE ILLNESSES 58
FIGURE 22 NUMBER OF FOODBORNE ILLNESSES ACROSS THE GLOBE, 2020 (MILLION) 59
FIGURE 23 US: TOP FIVE PATHOGENS CONTRIBUTING TO FOODBORNE ILLNESSES, 2020 59
5.3 MARKET DYNAMICS 60
FIGURE 24 ENTERIC DISEASE TESTING MARKET DYNAMICS 60
5.3.1 DRIVERS 60
5.3.1.1 Increase in the number of food recalls 60
FIGURE 25 EU: NUMBER OF FOOD RECALLS, 2017–2020 61
FIGURE 26 US: REASONS FOR RECALL OF FOOD, 2020 61
5.3.1.2 Rise in demand for convenience foods 61
FIGURE 27 READY-TO-EAT FOODS MOST AFFECTED BY FOOD RECALLS, 2020 62
FIGURE 28 RISE IN GLOBAL MEAT EXPORTS, 2017–2020 (KT) 62
5.3.1.3 Increase in global trade owing to higher disposable income among consumers 62
FIGURE 29 GLOBAL AGRI-FOOD EXPORT VALUE, BY KEY COUNTRY,
2016–2018 (USD BILLION) 63
FIGURE 30 COUNTRY-WISE PREPARED FOODS TRADE SCENARIOS, BY KEY COUNTRY, 2019 (USD MILLION) 63
5.3.2 RESTRAINTS 64
5.3.2.1 Lack of proper regulations governing pathogen testing in the developing economies 64
?
5.3.3 OPPORTUNITIES 64
5.3.3.1 Technological innovations in the food safety testing industry 64
5.3.3.2 R&D investment directed toward the development of PCR technology for improved pathogen testing 64
TABLE 2 R&D INVESTMENT BY MAJOR COMPANIES 65
5.3.4 CHALLENGES 65
5.3.4.1 High cost associated with testing of food and water 65
6 INDUSTRY TRENDS 66
6.1 INTRODUCTION 66
6.2 REGULATORY FRAMEWORK 66
6.2.1 INTRODUCTION 66
6.2.2 INTERNATIONAL BODIES FOR FOOD SAFETY STANDARDS AND REGULATIONS 66
6.2.2.1 Codex Alimentarius Commission (CAC) 66
6.2.2.2 Global Food Safety Initiative (GFSI) 66
6.2.3 NORTH AMERICA 67
6.2.3.1 US regulations 67
6.2.3.2 Mexico 68
6.2.3.3 Canada 68
6.2.4 EUROPE 69
6.2.4.1 Microbiological criteria regulation 70
6.2.4.2 General food law for food safety 70
6.2.4.3 Germany 70
6.2.4.4 UK 71
6.2.4.5 France 71
6.2.4.6 Italy 71
6.2.4.7 Poland 72
6.2.5 ASIA PACIFIC 72
6.2.5.1 China 72
TABLE 3 PATHOGEN LIMITS FOR FOOD 72
6.2.5.2 India 73
6.2.5.3 Japan 74
6.2.5.4 Australia 74
6.2.5.5 New Zealand 75
6.2.6 SOUTH AMERICA 75
6.2.6.1 Brazil 75
6.2.6.2 Ministry of Agriculture, Livestock, and Food Supply (MAPA) 75
6.2.6.3 Ministry of Health (MS) 75
6.2.6.4 Argentina 76
6.3 PORTER’S FIVE FORCES ANALYSIS 77
TABLE 4 ENTERIC DISEASE TESTING MARKET: PORTER’S FIVE FORCES ANALYSIS 77
6.3.1 THREAT OF NEW ENTRANTS 77
6.3.2 THREAT OF SUBSTITUTES 77
6.3.3 BARGAINING POWER OF SUPPLIERS 78
6.3.4 BARGAINING POWER OF BUYERS 78
6.3.5 DEGREE OF COMPETITION 78
6.4 MARKET ECOSYSTEM 79
FIGURE 31 ENTERIC DISEASE TESTING MARKET ECOSYSTEM MAP 79
6.4.1 UPSTREAM 79
6.4.2 DOWNSTREAM 79
TABLE 5 COMPANY MARKET ECOSYSTEM 80
6.5 SUPPLY CHAIN ANALYSIS 81
FIGURE 32 REGULATORY BODIES: ENTERIC DISEASE TESTING MARKET 81
6.5.1 R&D 82
6.5.2 PRODUCTION 82
6.5.3 PROCESSING & TRANSFORMING 82
6.5.4 TRANSPORTATION 82
6.5.5 FINAL PREPARATION 82
6.5.6 DISTRIBUTION 82
6.6 TECHNOLOGY ANALYSIS 83
6.7 PATENT ANALYSIS 84
FIGURE 33 PATENT ANALYSIS, 2017-2020 84
TABLE 6 KEY PATENTS FILED IN THE ENTERIC DISEASES TESTING MARKET,
2018- 2021 85
6.8 CASE STUDIES 85
TABLE 7 AUTOMATED PATHOGEN DETECTION USING VIDAS ADVANCED TESTING SOLUTION 85
6.9 DISRUPTIONS IMPACTING BUYERS IN THE MARKET 86
FIGURE 34 THE DEMAND FOR CONVENIENCE FOODS IS DRIVING THE MARKET FOR ENTERIC DISEASE TESTING IN FROZEN FRUITS & VEGETABLES 86
6.10 IMPACT OF COVID-19 ON MARKET DYNAMICS 86
6.10.1 COVID-19 INCREASED THE DEMAND FOR FOOD SAFETY AND ASSESSMENT 87
6.10.2 COVID-19 HAS SHIFTED THE FOCUS TOWARDS GENERAL HYGIENE SERVICES FROM FOOD SAFETY 87
7 ENTERIC DISEASE TESTING MARKET, BY PATHOGEN 88
7.1 INTRODUCTION 89
FIGURE 35 ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN,
2021 VS. 2026 (USD MILLION) 89
TABLE 8 PATHOGENESIS OF COMMON PATHOGENS 90
FIGURE 36 US: FOODBORNE DISEASE OUTBREAKS, OUTBREAK-ASSOCIATED ILLNESSES, AND HOSPITALIZATIONS, 2019 90
TABLE 9 US: INCIDENCE OF BACTERIAL AND PARASITIC INFECTIONS, 2019 91
TABLE 10 ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN,
2016–2020 (USD MILLION) 91
TABLE 11 ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN,
2021–2026 (USD MILLION) 92
7.1.1 COVID-19 IMPACT ON THE ENTERIC DISEASE TESTING MARKET,
BY PATHOGEN 92
7.1.1.1 Realistic Scenario 92
TABLE 12 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY PATHOGEN, 2016–2020 (USD MILLION) 92
TABLE 13 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY PATHOGEN, 2021–2026 (USD MILLION) 93
7.1.1.2 Optimistic Scenario 93
TABLE 14 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY PATHOGEN, 2016–2020 (USD MILLION) 93
TABLE 15 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY PATHOGEN, 2021–2026 (USD MILLION) 94
7.1.1.3 Pessimistic Scenario 94
TABLE 16 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY PATHOGEN, 2016–2020 (USD MILLION) 94
TABLE 17 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY PATHOGEN, 2021–2026 (USD MILLION) 95
7.1.2 E. COLI 95
7.1.2.1 Proper food safety testing can limit the incidences of E. coli food poisoning 95
FIGURE 37 US: ANNUAL NUMBER OF E. COLI OUTBREAKS, 2009–2018 96
FIGURE 38 TRANSMISSION CYCLE OF ETEC (ENTEROTOXIGENIC E. COLI) 96
TABLE 18 E. COLI TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT,
2016–2020 (USD MILLION) 97
TABLE 19 E. COLI TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT,
2021–2026 (USD MILLION) 97
7.1.3 SALMONELLA 98
7.1.3.1 Salmonella foodborne infection is found to be severe during summer than in winter 98
FIGURE 39 US: SALMONELLA OUTBREAKS, BY NUMBER AND CAUSE, 2009–2018 98
TABLE 20 SALMONELLA TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT,
2016–2020 (USD MILLION) 98
TABLE 21 SALMONELLA TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT,
2021–2026 (USD MILLION) 99
7.1.4 CAMPYLOBACTER 99
7.1.4.1 WHO is strengthening disease surveillance to prevent foodborne illness 99
FIGURE 40 US: ANNUAL CAMPYLOBACTER OUTBREAKS, 2009–2018 100
TABLE 22 CAMPYLOBACTER TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT,
2016–2020 (USD MILLION) 100
TABLE 23 CAMPYLOBACTER TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT,
2021–2026 (USD MILLION) 100
7.1.5 LISTERIA 101
7.1.5.1 L. monocytogenes causes high hospitalization rate than any other foodborne pathogen 101
TABLE 24 LISTERIA TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT,
2016–2020 (USD MILLION) 101
TABLE 25 LISTERIA TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT,
2021–2026 (USD MILLION) 101
7.1.6 OTHER PATHOGENS 102
TABLE 26 OTHER PATHOGENS TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION) 102
TABLE 27 OTHER PATHOGENS TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION) 102
8 ENTERIC DISEASE TESTING MARKET, BY END USE 103
8.1 INTRODUCTION 104
FIGURE 41 EU: FREQUENCY DISTRIBUTION OF FOODBORNE OUTBREAKS THROUGH FOODS OF NON-ANIMAL ORIGIN, 2019 104
FIGURE 42 ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2021 VS. 2026 (USD MILLION) 104
TABLE 28 ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2016–2020 (USD MILLION) 105
TABLE 29 ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2021–2026 (USD MILLION) 105
TABLE 30 ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT,
2016–2020 (USD MILLION) 105
TABLE 31 ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT,
2021–2026 (USD MILLION) 106
8.1.1 COVID-19 IMPACT ON THE ENTERIC DISEASE TESTING MARKET, BY END USE 106
8.1.1.1 Realistic scenario 106
TABLE 32 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY END USE, 2016–2020 (USD MILLION) 106
TABLE 33 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY END USE, 2021–2026 (USD MILLION) 107
8.1.1.2 Optimistic scenario 107
TABLE 34 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY END USE, 2016–2020 (USD MILLION) 107
TABLE 35 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY END USE, 2021–2026 (USD MILLION) 107
8.1.1.3 Pessimistic scenario 108
TABLE 36 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY END USE, 2016–2020 (USD MILLION) 108
TABLE 37 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY END USE, 2021–2026 (USD MILLION) 108
8.2 FOOD 108
8.2.1 MEAT & POULTRY PRODUCTS TO PROVIDE MORE SCOPE FOR FOOD TESTING 108
TABLE 38 ENTERIC DISEASE TESTING MARKET FOR FOOD SOURCE, BY FOODBORNE PATHOGENS 109
FIGURE 43 EU: FOODBORNE DISEASE OUTBREAKS, 2017 110
TABLE 39 EU: OCCURRENCE OF CAMPYLOBACTER IN MAJOR FOOD CATEGORIES 110
TABLE 40 US: FOOD RECALLS, 2020 111
TABLE 41 ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY REGION,
2016–2020 (USD MILLION) 112
TABLE 42 ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY REGION,
2021–2026 (USD MILLION) 113
TABLE 43 ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY PATHOGEN,
2016–2020 (USD MILLION) 113
TABLE 44 ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY PATHOGEN,
2021–2026 (USD MILLION) 113
8.2.2 MEAT, POULTRY, AND SEAFOOD 114
8.2.2.1 Unclean slaughterhouses and processing plants are the key contributors to bacterial contamination 114
FIGURE 44 EU: FREQUENCY DISTRIBUTION OF FOODBORNE OUTBREAKS THROUGH FOODS OF ANIMAL ORIGIN, 2019 114
TABLE 45 ENTERIC DISEASE TESTING MARKET SIZE IN MEAT, POULTRY, AND SEAFOOD, BY REGION, 2016–2020 (USD MILLION) 115
TABLE 46 ENTERIC DISEASE TESTING MARKET SIZE IN MEAT, POULTRY, AND SEAFOOD, BY REGION, 2021–2026 (USD MILLION) 115
TABLE 47 ENTERIC DISEASE TESTING MARKET SIZE IN MEAT, POULTRY, & SEAFOOD,
BY PATHOGEN, 2016–2020 (USD MILLION) 115
TABLE 48 ENTERIC DISEASE TESTING MARKET SIZE IN MEAT, POULTRY, & SEAFOOD,
BY PATHOGEN, 2021–2026 (USD MILLION) 116
8.2.3 DAIRY PRODUCTS 116
8.2.3.1 Unhygienic storage conditions lead to contamination of dairy products 116
FIGURE 45 EU: FREQUENCY DISTRIBUTION OF ILLNESSES IN DAIRY PRODUCTS, 2019 117
TABLE 49 ENTERIC DISEASE TESTING MARKET SIZE IN DAIRY PRODUCTS, BY REGION, 2016–2020 (USD MILLION) 117
TABLE 50 ENTERIC DISEASE TESTING MARKET SIZE IN DAIRY PRODUCTS, BY REGION, 2021–2026 (USD MILLION) 117
TABLE 51 ENTERIC DISEASE TESTING MARKET SIZE IN DAIRY PRODUCTS,
BY PATHOGEN, 2016–2020 (USD MILLION) 118
TABLE 52 ENTERIC DISEASE TESTING MARKET SIZE IN DAIRY PRODUCTS,
BY PATHOGEN, 2021–2026 (USD MILLION) 118
8.2.4 PROCESSED FOOD 118
8.2.4.1 Ready-To-Eat foods are gaining more traction among consumers 118
TABLE 53 ENTERIC DISEASE TESTING MARKET SIZE IN PROCESSED FOOD, BY REGION, 2016–2020 (USD MILLION) 119
TABLE 54 ENTERIC DISEASE TESTING MARKET SIZE FOR PROCESSED FOOD,
BY REGION, 2021–2026 (USD MILLION) 119
TABLE 55 ENTERIC DISEASE TESTING MARKET IN PROCESSED FOODS, BY PATHOGEN, 2016–2020 (USD MILLION) 120
TABLE 56 ENTERIC DISEASE TESTING MARKET SIZE IN PROCESSED FOODS,
BY PATHOGEN, 2021–2026 (USD MILLION) 120
8.2.5 FRUITS & VEGETABLES 120
8.2.5.1 Good handling practices can help in the safe production of fresh produce 120
TABLE 57 ENTERIC DISEASE TESTING MARKET SIZE IN FRUITS & VEGETABLES,
BY REGION, 2016–2020 (USD MILLION) 121
TABLE 58 ENTERIC DISEASE TESTING MARKET SIZE IN FRUITS & VEGETABLES,
BY REGION, 2021–2026 (USD MILLION) 121
TABLE 59 ENTERIC DISEASE TESTING MARKET SIZE IN FRUITS & VEGETABLES,
BY PATHOGEN, 2016–2020 (USD MILLION) 121
TABLE 60 ENTERIC DISEASE TESTING MARKET SIZE IN FRUITS & VEGETABLES,
BY PATHOGEN, 2021–2026 (USD MILLION) 122
8.2.6 OTHER FOOD APPLICATIONS 122
TABLE 61 ENTERIC DISEASE TESTING MARKET SIZE IN OTHER FOOD APPLICATIONS,
BY REGION, 2016–2020 (USD MILLION) 123
TABLE 62 ENTERIC DISEASE TESTING MARKET SIZE IN OTHER FOOD APPLICATIONS,
BY REGION, 2021–2026 (USD MILLION) 123
TABLE 63 ENTERIC DISEASE TESTING MARKET SIZE IN OTHER FOOD APPLICATIONS,
BY PATHOGEN, 2016–2020 (USD MILLION) 123
TABLE 64 ENTERIC DISEASE TESTING MARKET SIZE IN OTHER FOOD APPLICATIONS,
BY PATHOGEN, 2021–2026 (USD MILLION) 124
8.3 WATER 124
8.3.1 POOR HYGIENIC CONDITIONS LEAD TO WATERBORNE DISEASES IN DEVELOPING REGIONS 124
TABLE 65 ENTERIC DISEASE TESTING MARKET SIZE IN WATER, BY REGION,
2016–2020 (USD MILLION) 124
TABLE 66 ENTERIC DISEASE TESTING MARKET SIZE IN WATER, BY REGION,
2021–2026 (USD MILLION) 125
TABLE 67 ENTERIC DISEASE TESTING MARKET SIZE IN WATER, BY PATHOGEN,
2016–2020 (USD MILLION) 125
TABLE 68 ENTERIC DISEASE TESTING MARKET SIZE IN WATER, BY PATHOGEN,
2021–2026 (USD MILLION) 125
9 ENTERIC DISEASE TESTING MARKET, BY TECHNOLOGY 126
9.1 INTRODUCTION 127
FIGURE 46 ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY,
2021 VS. 2026 (USD MILLION) 127
TABLE 69 ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY,
2016–2020 (USD MILLION) 127
TABLE 70 ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY,
2021–2026 (USD MILLION) 128
9.1.1 COVID-19 IMPACT ON THE ENTERIC DISEASE TESTING MARKET,
BY TECHNOLOGY 128
9.1.1.1 Realistic scenario 128
TABLE 71 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY TECHNOLOGY, 2016–2020 (USD MILLION) 128
TABLE 72 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY TECHNOLOGY, 2021–2026 (USD MILLION) 128
9.1.1.2 Optimistic scenario 129
TABLE 73 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY TECHNOLOGY, 2016–2020 (USD MILLION) 129
TABLE 74 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY TECHNOLOGY, 2021–2026 (USD MILLION) 129
9.1.1.3 Pessimistic scenario 129
TABLE 75 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY TECHNOLOGY, 2016–2020 (USD MILLION) 129
TABLE 76 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY TECHNOLOGY, 2021–2026 (USD MILLION) 129
9.2 TRADITIONAL 130
9.2.1 CULTURAL TECHNIQUES HAVE BEEN PREFERRED FOR BOTH READY-TO-EAT FOODS AND FRESH PRODUCE 130
TABLE 77 TRADITIONAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION,
2016–2020 (USD MILLION) 130
TABLE 78 TRADITIONAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION,
2021–2026 (USD MILLION) 131
9.3 RAPID 131
TABLE 79 ENTERIC DISEASE TESTING MARKET SIZE FOR RAPID TECHNOLOGY,
BY REGION, 2016–2020 (USD MILLION) 132
TABLE 80 RAPID ENTERIC DISEASE TESTING MARKET SIZE, BY REGION,
2021–2026 (USD MILLION) 132
TABLE 81 RAPID ENTERIC DISEASE TESTING MARKET SIZE, BY SUBSEGMENT,
2016–2020 (USD MILLION) 132
TABLE 82 RAPID ENTERIC DISEASE TESTING MARKET SIZE, BY SUBSEGMENT,
2021–2026 (USD MILLION) 133
9.3.1 CONVENIENCE-BASED 133
9.3.1.1 Helps detect microorganisms based on their biochemical reactions under standard growth conditions 133
9.3.2 POLYMERASE CHAIN REACTION (PCR) 133
9.3.2.1 Real-time PCR involves fluorescent ethidium bromide monoazide dye that prevent the detection of dead organisms 133
9.3.3 IMMUNOASSAY 134
9.3.3.1 ELISA is based on the protein’s characteristic of binding to specific enzyme-labeled antibodies 134
9.3.4 CHROMATOGRAPHY & SPECTROMETRY 135
9.3.4.1 Inductively Coupled Plasma (ICP) is one of the major advancements of mass spectrometry 135
10 ENTERIC DISEASE TESTING MARKET, BY REGION 136
10.1 INTRODUCTION 137
FIGURE 47 REGION-WISE FOOD SAFETY EVENTS, 2020 137
FIGURE 48 US ESTIMATED TO GROW AT THE HIGHEST GROWTH RATE IN THE ENTERIC DISEASE TESTING MARKET, 2021–2026 138
TABLE 83 ENTERIC DISEASE TESTING MARKET SIZE, BY REGION,
2016–2020 (USD MILLION) 138
TABLE 84 ENTERIC DISEASE TESTING MARKET SIZE, BY REGION,
2021–2026 (USD MILLION) 139
10.1.1 COVID-19 IMPACT ON THE ENTERIC DISEASE TESTING MARKET, BY REGION 139
10.1.1.1 Realistic scenario 139
TABLE 85 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2016–2020 (USD MILLION) 139
TABLE 86 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2021–2026 (USD MILLION) 140
10.1.1.2 Optimistic scenario 140
TABLE 87 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY REGION, 2016–2020 (USD MILLION) 140
TABLE 88 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY REGION, 2021–2026 (USD MILLION) 140
10.1.1.3 Pessimistic scenario 141
TABLE 89 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY REGION, 2016–2020 (USD MILLION) 141
TABLE 90 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE,
BY REGION, 2021–2026 (USD MILLION) 141
10.2 NORTH AMERICA 141
FIGURE 49 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SNAPSHOT, 2020 142
TABLE 91 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2016–2020 (USD MILLION) 143
TABLE 92 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2021–2026 (USD MILLION) 143
TABLE 93 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION) 143
TABLE 94 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION) 144
TABLE 95 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2016–2020 (USD MILLION) 144
TABLE 96 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2021–2026 (USD MILLION) 144
10.2.1 US 145
10.2.1.1 FSIS is the regulating body that enforces food safety regulations 145
FIGURE 50 NUMBER OF DEATHS RELATED TO CONFIRMED INFECTIONS, BY PATHOGEN, 2010–2018 145
FIGURE 51 US: FOODBORNE PATHOGEN INCIDENCE RATE PER 100,000 PERSONS, 2010–2016 146
TABLE 97 US: ESTIMATED EFFECTS OF FOODBORNE AGENTS (2016) 146
FIGURE 52 US: INCIDENCES RELATED TO THE TOP FIVE FOODBORNE PATHOGENS, 2016 147
TABLE 98 US: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2016–2020 (USD MILLION) 147
TABLE 99 US: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2021–2026 (USD MILLION) 148
TABLE 100 US: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION) 148
TABLE 101 US: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION) 148
10.2.2 CANADA 149
10.2.2.1 Canadian government imposed stringent regulations on exports to ensure food safety 149
TABLE 102 CANADA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2016–2020 (USD MILLION) 149
TABLE 103 CANADA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2021–2026 (USD MILLION) 149
TABLE 104 CANADA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2016–2020 (USD MILLION) 150
TABLE 105 CANADA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2021–2026 (USD MILLION) 150
10.2.3 MEXICO 151
10.2.3.1 Rise in the number of foodborne disease cases has increased focus on food safety in the country 151
TABLE 106 MEXICO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2016–2020 (USD MILLION) 151
TABLE 107 MEXICO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2021–2026 (USD MILLION) 151
TABLE 108 MEXICO: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2016–2020 (USD MILLION) 152
TABLE 109 MEXICO: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2021–2026 (USD MILLION) 152
10.3 EUROPE 152
FIGURE 53 EU/EEA: DISTRIBUTION OF CONFIRMED CAMPYLOBACTERIOSIS CASES
AND RATES PER 100 000 POPULATION BY YEAR AND COUNTRY, 2013–2017 153
FIGURE 54 EUROPE: ENTERIC DISEASE TESTING MARKET SNAPSHOT, 2020 154
TABLE 110 EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY,
2016–2020 (USD MILLION) 155
TABLE 111 EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY,
2021–2026 (USD MILLION) 155
TABLE 112 EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2016–2020 (USD MILLION) 156
TABLE 113 EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2021–2026 (USD MILLION) 156
TABLE 114 EUROPE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2016–2020 (USD MILLION) 156
TABLE 115 EUROPE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2021–2026 (USD MILLION) 157
10.3.1 GERMANY 157
10.3.1.1 International food trade has increased food safety risks 157
FIGURE 55 GERMANY: ACTIVE FOOD TESTING CARRIED OUT FOR VARIOUS FOOD PATHOGENS IN MULTIPLE FOOD PRODUCTS, 2019 158
TABLE 116 GERMANY: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2016–2020 (USD MILLION) 158
TABLE 117 GERMANY: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2021–2026 (USD MILLION) 159
TABLE 118 GERMANY: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2016–2020 (USD MILLION) 159
TABLE 119 GERMANY: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2021–2026 (USD MILLION) 159
10.3.2 FRANCE 160
10.3.2.1 Large number of foodborne outbreaks in meat-based food encouraging the growth of enteric disease testing 160
TABLE 120 FRANCE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2016–2020 (USD MILLION) 160
TABLE 121 FRANCE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2021–2026 (USD MILLION) 160
TABLE 122 FRANCE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2016–2020 (USD MILLION) 161
TABLE 123 FRANCE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2021–2026 (USD MILLION) 161
10.3.3 SPAIN 161
10.3.3.1 Outbreak of listeriosis will have serious implications on the Spanish meat industry 161
TABLE 124 SPAIN: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2016–2020 (USD MILLION) 162
TABLE 125 SPAIN: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2021–2026 (USD MILLION) 162
TABLE 126 SPAIN: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION) 162
TABLE 127 SPAIN: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION) 163
10.3.4 ITALY 163
10.3.4.1 Products of animal origin products are found to be more problematic in this region 163
TABLE 128 ITALY: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2016–2020 (USD MILLION) 163
TABLE 129 ITALY: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2021–2026 (USD MILLION) 164
TABLE 130 ITALY: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION) 164
TABLE 131 ITALY: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION) 164
10.3.5 POLAND 165
10.3.5.1 Increase in incidences of Salmonella outbreaks drives awareness about food safety 165
TABLE 132 POLAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2016–2020 (USD MILLION) 165
TABLE 133 POLAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2021–2026 (USD MILLION) 165
TABLE 134 POLAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENTS, 2016–2020 (USD MILLION) 166
TABLE 135 POLAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2021–2026 (USD MILLION) 166
10.3.6 UK 167
10.3.6.1 Norovirus infection is estimated to occur every year in the UK 167
TABLE 136 UK: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2016–2020 (USD MILLION) 167
TABLE 137 UK: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2021–2026 (USD MILLION) 167
TABLE 138 UK: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016–2020 (USD MILLION) 167
TABLE 139 UK: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021–2026 (USD MILLION) 168
10.3.7 REST OF EUROPE 168
TABLE 140 REST OF EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016–2020 (USD MILLION) 168
TABLE 141 REST OF EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021–2026 (USD MILLION) 169
TABLE 142 REST OF EUROPE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2016–2020 (USD MILLION) 169
TABLE 143 REST OF EUROPE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2021–2026 (USD MILLION) 169
10.4 ASIA PACIFIC 170
TABLE 144 ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE,
BY COUNTRY/REGION, 2016–2020 (USD MILLION) 170
TABLE 145 ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE,
BY COUNTRY/REGION, 2021–2026 (USD MILLION) 170
TABLE 146 ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2016–2020 (USD MILLION) 171
TABLE 147 ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE,
2021–2026 (USD MILLION) 171
TABLE 148 ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2016–2020 (USD MILLION) 171
TABLE 149 ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD,
BY SUBSEGMENT, 2021–2026 (USD MILLION) 172
10.4.1 JAPAN 172
10.4.1.1 E. coli to be the major pathogen found to affect people 172
TABLE 150 JAPAN: ENTERIC DISEASE TESTIN11 COMPETITIVE LANDSCAPE 195
11.1 OVERVIEW 195
11.2 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN THE ENTERIC DISEASES TESTING MARKET 196
11.3 MARKET SHARE ANALYSIS, 2020 197
FIGURE 56 MARKET SHARE OBTAINED BY DOMINANT AND OTHER PLAYERS 197
11.4 COVID-19-SPECIFIC COMPANY RESPONSE 198
11.4.1 SGS SA 198
11.4.2 MERCK KGAA 198
11.4.3 EUROFINS SCIENTIFIC 198
11.5 COMPANY EVALUATION QUADRANT (KEY PLAYERS) 198
11.5.1 STARS 199
11.5.2 EMERGING LEADERS 199
11.5.3 PERVASIVE PLAYERS 199
11.5.4 PARTICIPANTS 199
FIGURE 57 ENTERIC DISEASE TESTING MARKET: COMPANY EVALUATION QUADRANT, 2020 (KEY PLAYERS) 200
11.6 PRODUCT FOOTPRINT 201
TABLE 206 COMPANY FOOTPRINT, BY TECHNOLOGY 201
TABLE 207 COMPANY FOOTPRINT, BY END-USE 202
TABLE 208 COMPANY FOOTPRINT, BY REGION 203
11.7 COMPANY EVALUATION QUADRANT (START-UP/SME) 204
11.7.1 PROGRESSIVE COMPANIES 204
11.7.2 STARTING BLOCKS 204
11.7.3 RESPONSIVE COMPANIES 204
11.7.4 DYNAMIC COMPANIES 204
FIGURE 58 ENTERIC DISEASE TESTING MARKET: COMPANY EVALUATION QUADRANT, 2020 (START-UPS/SME) 205
11.8 COMPETITIVE SCENARIO 205
11.8.1 NEW PRODUCTS LAUNCHES 205
TABLE 209 ENTERIC DISEASE TESTING MARKET: NEW PRODUCT LAUNCHES, JULY 2019 205
11.8.2 DEALS 206
TABLE 210 ENTERIC DISEASE TESTING MARKET: DEALS, MAY 2017- JULY 2021 206
11.8.3 OTHER DEVELOPMENTS 207
TABLE 211 ENTERIC DISEASE TESTING MARKET: OTHER DEVELOPMENTS,
MAY 2018- JUNE 2021 207
12 COMPANY PROFILES 208
(Business overview, Products offered, Recent developments & MnM View)*
12.1 KEY COMPANIES 208
12.1.1 SGS SA 208
TABLE 212 SGS SA: BUSINESS OVERVIEW 208
FIGURE 59 SGS SA: COMPANY SNAPSHOT 209
TABLE 213 SGS SA: PRODUCT OFFERINGS 209
TABLE 214 SGA SA: DEALS 210
TABLE 215 SGS SA: OTHERS 210
12.1.2 MERCK KGAA 212
TABLE 216 MERCK KGAA: BUSINESS OVERVIEW 212
FIGURE 60 MERCK KGAA: COMPANY SNAPSHOT 213
TABLE 217 MERCK KGAA: PRODUCT OFFERINGS 213
12.1.3 THERMO FISHER SCIENTIFIC INC. 215
TABLE 218 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW 215
FIGURE 61 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT 216
TABLE 219 THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERINGS 216
TABLE 220 THERMO FISHER SCIENTIFIC INC.: DEALS 218
12.1.4 EUROFINS SCIENTIFIC 219
TABLE 221 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW 219
FIGURE 62 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT 220
TABLE 222 EUROFINS SCIENTIFIC: PRODUCT OFFERINGS 220
TABLE 223 EUROFINS SCIENTIFIC: DEALS 221
TABLE 224 EUROFINS SCIENTIFIC: OTHER DEVELOPMENTS 222
12.1.5 ALS LIMITED 223
TABLE 225 ALS LIMITED: BUSINESS OVERVIEW 223
FIGURE 63 ALS LIMITED: COMPANY SNAPSHOT 223
TABLE 226 ALS LIMITED: PRODUCT OFFERINGS 224
TABLE 227 ALS LIMITED: DEALS 224
TABLE 228 ALS LIMITED: OTHER DEVELOPMENTS 225
12.1.6 ASURE QUALITY 226
TABLE 229 ASURE QUALITY: BUSINESS OVERVIEW 226
FIGURE 64 ASURE QUALITY: COMPANY SNAPSHOT 226
TABLE 230 ASURE QUALITY: PRODUCT OFFERINGS 227
12.1.7 BUREAU VERITAS 228
TABLE 231 BUREAU VERITAS: BUSINESS OVERVIEW 228
FIGURE 65 BUREAU VERITAS: COMPANY SNAPSHOT 229
TABLE 232 BUREAU VERITAS: PRODUCT OFFERINGS 229
12.1.8 INTERTEK 231
TABLE 233 INTERTEK: BUSINESS OVERVIEW 231
FIGURE 66 INTERTEK: COMPANY SNAPSHOT 232
TABLE 234 INTERTEK: PRODUCT OFFERINGS 232
TABLE 235 INTERTEK: DEALS 233
12.1.9 BIO-RAD LABORATORIES, INC. 234
TABLE 236 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW 234
FIGURE 67 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT 234
TABLE 237 BIO-RAD LABORATORIES, INC.: PRODUCT OFFERINGS 235
12.1.10 BECTON DICKINSON 237
TABLE 238 BECTON DICKINSON: BUSINESS OVERVIEW 237
FIGURE 68 BECTON DICKINSON: COMPANY SNAPSHOT 238
TABLE 239 BECTON DICKINSON: PRODUCT OFFERINGS 238
12.1.11 3M 240
TABLE 240 3M: BUSINESS OVERVIEW 240
FIGURE 69 3M: COMPANY SNAPSHOT 240
TABLE 241 3M: PRODUCT OFFERINGS 241
12.1.12 PERKINELMER, INC. 242
TABLE 242 PERKINELMER, INC.: BUSINESS OVERVIEW 242
FIGURE 70 PERKINELMER, INC.: COMPANY SNAPSHOT 243
TABLE 243 PERKINELMER, INC.: PRODUCT OFFERINGS 244
12.1.13 NEOGEN CORPORATION 245
TABLE 244 NEOGEN CORPORATION: BUSINESS OVERVIEW 245
FIGURE 71 NEOGEN CORPORATION: COMPANY SNAPSHOT 245
TABLE 245 NEOGEN CORPORATION: PRODUCT OFFERINGS 246
12.1.14 M?RIEUX NUTRISCIENCES 248
TABLE 246 M?RIEUX NUTRISCIENCES: BUSINESS OVERVIEW 248
TABLE 247 M?RIEUX NUTRISCIENCES: PRODUCT OFFERINGS 248
TABLE 248 M?RIEUX NUTRISCIENCES: DEALS 249
12.1.15 T?V S?D 250
TABLE 249 T?V S?D: BUSINESS OVERVIEW 250
TABLE 250 T?V S?D: PRODUCT OFFERINGS 250
*Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.
?
12.2 OTHER PLAYERS 251
12.2.1 HARDY DIAGNOSTICS 251
TABLE 251 HARDY DIAGNOSTICS: BUSINESS OVERVIEW 251
TABLE 252 HARDY DIAGNOSTICS: PRODUCT OFFERINGS 251
TABLE 253 HARDY DIAGNOSTICS: NEW PRODUCT LAUNCH 252
12.2.2 ROMER LABS 253
TABLE 254 ROMER LABS: BUSINESS OVERVIEW 253
TABLE 255 ROMER LABS: PRODUCT OFFERINGS 253
12.2.3 NOVA BIOLOGICALS 254
TABLE 256 NOVA BIOLOGICALS: BUSINESS OVERVIEW 254
TABLE 257 NOVA BIOLOGICALS: PRODUCT OFFERINGS 254
12.2.4 SYMBIO LABORATORIES 255
TABLE 258 SYMBIO LABORATORIES: BUSINESS OVERVIEW 255
TABLE 259 SYMBIO LABORATORIES: PRODUCT OFFERINGS 255
12.2.5 CERTIFIED LABORATORIES 256
13 ADJACENT AND RELATED MARKETS 257
13.1 INTRODUCTION 257
TABLE 260 ADJACENT MARKETS TO ENTERIC DISEASE TESTING MARKET 257
13.2 LIMITATIONS 257
13.3 FOOD PATHOGEN TESTING MARKET 257
13.3.1 MARKET DEFINITION 257
13.3.2 MARKET OVERVIEW 258
TABLE 261 E. COLI MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 259
TABLE 262 SALMONELLA MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION) 259
TABLE 263 CAMPYLOBACTER MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 259
TABLE 264 LISTERIA MARKET SIZE, BY REGION, 2013–2020 (USD MILLION) 260
13.4 FOOD TESTING KITS MARKET 260
13.4.1 MARKET DEFINITION 260
13.4.2 MARKET OVERVIEW 260
TABLE 265 FOOD TESTING KITS MARKET SIZE IN MEAT, POULTRY,
AND SEAFOOD PRODUCTS, BY REGION, 2015–2022 (USD MILLION) 261
TABLE 266 FOOD TESTING KITS MARKET SIZE IN DAIRY PRODUCTS, BY REGION,
2015–2022 (USD MILLION) 261
TABLE 267 FOOD TESTING KITS MARKET SIZE IN PROCESSED FOOD, BY REGION,
2015–2022 (USD MILLION) 261
TABLE 268 FOOD TESTING KITS MARKET SIZE IN FRUITS & VEGETABLES, BY REGION, 2015–2022 (USD MILLION) 262
?
13.5 MICROBIAL WATER TESTING MARKET 262
13.5.1 MARKET DEFINITION 262
13.5.2 MARKET OVERVIEW 263
TABLE 269 MICROBIAL WATER TESTING SOLUTIONS MARKET SIZE, BY WATER TYPE, 2015–2022 (USD MILLION) 263
TABLE 270 MICROBIAL WATER TESTING SOLUTIONS MARKET SIZE, BY TYPE,
2015–2022 (USD MILLION) 263
TABLE 271 DRINKING & BOTTLED MICROBIAL WATER TESTING SOLUTIONS MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION) 264
TABLE 272 INDUSTRIAL MICROBIAL WATER TESTING SOLUTIONS MARKET SIZE, BY TYPE, 2015–2022 (USD MILLION) 264
14 APPENDIX 265
14.1 DISCUSSION GUIDE 265
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS? SUBSCRIPTION PORTAL 269
14.3 AVAILABLE CUSTOMIZATIONS 271
14.4 RELATED REPORTS 272
14.5 AUTHOR DETAILS 273